Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE).
Journal: Pediatric dermatology
Published: September 25, 2025
Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis.
Journal: Journal of drugs in dermatology : JDD
Published: June 04, 2025
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial.
Journal: Journal of the American Academy of Dermatology
Published: April 10, 2025
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.
Journal: Dermatology and therapy
Published: October 31, 2024
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial.
Journal: Pediatric dermatology
Published: October 01, 2024
Topical steroid withdrawal syndrome: developing diagnostic criteria through a modified Delphi method.
Journal: The British journal of dermatology
Published: March 13, 2024
Long-Term Efficacy of Dupilumab in Alopecia Areata.
Journal: The American journal of case reports
Published: June 21, 2022
Mucinous carcinoma: a translucent blue papule on an 89-year-old man.
Journal: Skinmed
Published: September 24, 2013
Multiples in dermatology: markers for special considerations in diagnosis, therapy, and prognosis.
Journal: Journal of drugs in dermatology : JDD
Published: July 11, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026